|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.51 EUR | -1.40% |
|
-48.41% | -58.32% |
| May. 15 | Earnings Flash (BFRI) BIOFRONTERA Reports Q1 Revenue $7.9M, vs. Street Est of $10.9M | MT |
| Apr. 30 | Biofrontera AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Biofrontera AG reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EUR 32.25 million compared to EUR 25.74 million a year ago. Net loss was EUR 0.369 million compared to EUR 44.17 million a year ago.
Basic loss per share from continuing operations was EUR 0.01 compared to EUR 0.77 a year ago. Diluted loss per share from continuing operations was EUR 0.01 compared to EUR 0.77 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -58.32% | 11.45M | |
| +37.78% | 705B | |
| +32.82% | 583B | |
| -3.51% | 364B | |
| +19.94% | 332B | |
| +5.14% | 291B | |
| +16.64% | 238B | |
| -4.13% | 210B | |
| +10.63% | 209B | |
| +9.32% | 169B |
BIOFRONTERA AG 
